UBC researchers are creating biotech companies that are helping to drive health innovation and fuel British Columbia’s economy. Acuitas is among a growing number of UBC spin-off companies that are developing cutting-edge treatments and potential cures for human diseases. Others include AbCellera and Precision NanoSystems.
The common theme amongst each company? They all began at UBC, first as research in university laboratories and then as start-up companies. The university provides entrepreneurial support to researchers who have technology determined to have a potentially high societal impact that would be best realized through creating a spin-off company.
